Evaluating Valuation as Baricitinib Advances Toward Expanded Approval for Adolescent Alopecia Areata
New data from the Phase 3 BRAVE-AA-PEDS trial highlights baricitinib’s strong performance in adolescents facing severe alopecia areata.…
Browsing Tag
Incyte
1 post